ACM
AlphaCrest Capital Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,724
| Closed | -$411K | – | 830 |
|
|
2022
Q3 | $411K | Buy |
7,724
+1,093
| +16% | +$58.2K | 0.03% | 1052 |
|
|
2022
Q2 | $387K | Buy |
+6,631
| New | +$387K | 0.02% | 1033 |
|
|
2022
Q1 | – | Sell |
-11,465
| Closed | -$690K | – | 1365 |
|
|
2021
Q4 | $690K | Buy |
11,465
+1,203
| +12% | +$72.4K | 0.03% | 962 |
|
|
2021
Q3 | $575K | Sell |
10,262
-7,237
| -41% | -$406K | 0.03% | 857 |
|
|
2021
Q2 | $1.06M | Buy |
+17,499
| New | +$1.06M | 0.05% | 639 |
|
|
2021
Q1 | – | Sell |
-16,173
| Closed | -$968K | – | 1273 |
|
|
2020
Q4 | $968K | Buy |
16,173
+12,759
| +374% | +$764K | 0.08% | 331 |
|
|
2020
Q3 | $205K | Sell |
3,414
-1,456
| -30% | -$87.4K | 0.02% | 1030 |
|
|
2020
Q2 | $256K | Buy |
+4,870
| New | +$256K | 0.04% | 707 |
|
|
2020
Q1 | – | Sell |
-11,599
| Closed | -$525K | – | 1211 |
|
|
2019
Q4 | $525K | Sell |
11,599
-14,838
| -56% | -$672K | 0.04% | 758 |
|
|
2019
Q3 | $1.01M | Buy |
26,437
+3,095
| +13% | +$118K | 0.06% | 567 |
|
|
2019
Q2 | $1.02M | Buy |
23,342
+6,002
| +35% | +$261K | 0.09% | 390 |
|
|
2019
Q1 | $660K | Buy |
17,340
+8,440
| +95% | +$321K | 0.1% | 348 |
|
|
2018
Q4 | $383K | Buy |
+8,900
| New | +$383K | 0.11% | 346 |
|